181 related articles for article (PubMed ID: 10672063)
1. Loss of expression of transforming growth factor beta type II receptor correlates with high tumour grade in human breast in-situ and invasive carcinomas.
Gobbi H; Arteaga CL; Jensen RA; Simpson JF; Dupont WD; Olson SJ; Schuyler PA; Plummer WD; Page DL
Histopathology; 2000 Feb; 36(2):168-77. PubMed ID: 10672063
[TBL] [Abstract][Full Text] [Related]
2. High tumor grade in salivary gland mucoepidermoid carcinomas and loss of expression of transforming growth factor beta receptor type II.
Dillard DG; Muller S; Cohen C; Bloch D; Del Gaudio JM; Gal AA
Arch Otolaryngol Head Neck Surg; 2001 Jun; 127(6):683-6. PubMed ID: 11405868
[TBL] [Abstract][Full Text] [Related]
3. Transforming growth factor-beta and breast cancer risk in women with mammary epithelial hyperplasia.
Gobbi H; Dupont WD; Simpson JF; Plummer WD; Schuyler PA; Olson SJ; Arteaga CL; Page DL
J Natl Cancer Inst; 1999 Dec; 91(24):2096-101. PubMed ID: 10601380
[TBL] [Abstract][Full Text] [Related]
4. The expression levels and the differential expression of transforming growth factor-beta receptors in dermatofibroma and dermatofibrosarcoma protuberans.
Kubo M; Ihn H; Yamane K; Tamaki K
Br J Dermatol; 2006 May; 154(5):919-25. PubMed ID: 16634896
[TBL] [Abstract][Full Text] [Related]
5. Investigation of immunohistochemical ERα, ERβ and ERβcx expressions in normal and neoplastic breast tissues.
Bozkurt KK; Kapucuoğlu N
Pathol Res Pract; 2012 Mar; 208(3):133-9. PubMed ID: 22336175
[TBL] [Abstract][Full Text] [Related]
6. [Detection and clinical significance of Notch1 methylation in breast cancer and intraductal proliferative breast lesions].
Zhang N; Sun ZZ; Li F; Cao YW; Zhao CX; Liang WH; Sun HP; Li HA; Fu XG
Zhonghua Bing Li Xue Za Zhi; 2011 May; 40(5):324-9. PubMed ID: 21756827
[TBL] [Abstract][Full Text] [Related]
7. Regulation of transforming growth factor-beta type II receptor expression in human breast cancer MCF-7 cells by vitamin D3 and its analogues.
Wu G; Fan RS; Li W; Srinivas V; Brattain MG
J Biol Chem; 1998 Mar; 273(13):7749-56. PubMed ID: 9516484
[TBL] [Abstract][Full Text] [Related]
8. Multiple developmental pathways of highly aggressive breast cancers disclosed by comparison of histological grades and c-erbB-2 expression patterns in both the non-invasive and invasive portions.
Tsuda H; Hirohashi S
Pathol Int; 1998 Jul; 48(7):518-25. PubMed ID: 9701014
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of transforming growth factor beta type II receptor in laryngeal carcinogenesis.
Franchi A; Gallo O; Sardi I; Santucci M
J Clin Pathol; 2001 Mar; 54(3):201-4. PubMed ID: 11253131
[TBL] [Abstract][Full Text] [Related]
10. Correlation of astrocyte elevated gene-1, basic-fibroblast growth factor, beta-catenin, Ki-67, tumor necrosis factor-alfa with prognostic parameters in ductal carcinomas and ductal intraepithelial neoplasms.
Erdem H; Gundogdu B; Ankarali H; Yasar M; Sener E; Oktay M; Bahadir A; Uzunlar AK; Gursan N; Ozaydin I; Sahiner C
Niger J Clin Pract; 2015; 18(5):638-43. PubMed ID: 26096243
[TBL] [Abstract][Full Text] [Related]
11. Abnormal expression of Nek2 and β-catenin in breast carcinoma: clinicopathological correlations.
Wang S; Li W; Lv S; Wang Y; Liu Z; Zhang J; Liu T; Niu Y
Histopathology; 2011 Oct; 59(4):631-42. PubMed ID: 22014044
[TBL] [Abstract][Full Text] [Related]
12. Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.
Ottesen GL
APMIS Suppl; 2003; (108):1-67. PubMed ID: 12874968
[TBL] [Abstract][Full Text] [Related]
13. [Expression of Fascin-1 protein in breast cancer and its clinicopathologic correlation].
Wang C; Huang B; Wu Z; Sun X; Zeng Y; Wang Y
Zhonghua Bing Li Xue Za Zhi; 2014 Jul; 43(7):451-4. PubMed ID: 25327793
[TBL] [Abstract][Full Text] [Related]
14. Reduced expression of transforming growth factor beta type I receptor contributes to the malignancy of human colon carcinoma cells.
Wang J; Han W; Zborowska E; Liang J; Wang X; Willson JK; Sun L; Brattain MG
J Biol Chem; 1996 Jul; 271(29):17366-71. PubMed ID: 8663343
[TBL] [Abstract][Full Text] [Related]
15. A kinase-defective transforming growth factor-beta receptor type II is a dominant-negative regulator for human breast carcinoma MCF-7 cells.
Ko Y; Koli KM; Banerji SS; Li W; Zborowska E; Willson JK; Brattain MG; Arteaga CL
Int J Oncol; 1998 Jan; 12(1):87-94. PubMed ID: 9454891
[TBL] [Abstract][Full Text] [Related]
16. Expression patterns of angiogenic and lymphangiogenic factors in ductal breast carcinoma in situ.
Wülfing P; Kersting C; Buerger H; Mattsson B; Mesters R; Gustmann C; Hinrichs B; Tio J; Böcker W; Kiesel L
Br J Cancer; 2005 May; 92(9):1720-8. PubMed ID: 15841074
[TBL] [Abstract][Full Text] [Related]
17. Tissue expression of transforming growth factor-beta1 and its receptors: correlation with pathologic features and biochemical progression in patients undergoing radical prostatectomy.
Shariat SF; Menesses-Diaz A; Kim IY; Muramoto M; Wheeler TM; Slawin KM
Urology; 2004 Jun; 63(6):1191-7. PubMed ID: 15183988
[TBL] [Abstract][Full Text] [Related]
18. Similarity in expression of cell cycle proteins between in situ and invasive ductal breast lesions of same differentiation grade.
Mommers EC; Leonhart AM; Falix F; Michalides R; Meijer CJ; Baak JP; Diest PJ
J Pathol; 2001 Jul; 194(3):327-33. PubMed ID: 11439365
[TBL] [Abstract][Full Text] [Related]
19. Amplification of Her-2/neu gene in Her-2/neu-overexpressing and -nonexpressing breast carcinomas and their synchronous benign, premalignant, and metastatic lesions detected by FISH in archival material.
Xu R; Perle MA; Inghirami G; Chan W; Delgado Y; Feiner H
Mod Pathol; 2002 Feb; 15(2):116-24. PubMed ID: 11850540
[TBL] [Abstract][Full Text] [Related]
20. Gene expression and protein deposition of major basement membrane components and TGF-beta 1 in human breast cancer.
Nerlich AG; Wiest I; Wagner E; Sauer U; Schleicher ED
Anticancer Res; 1997; 17(6D):4443-9. PubMed ID: 9494547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
